Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
56 studies found for:    "Hereditary angioedema"
Show Display Options
Rank Status Study
21 Completed
Has Results
C1 Esterase Inhibitor in Hereditary Angioedema (HAE)(Extension Study)
Condition: Hereditary Angioedema
Intervention: Drug: C1 Esterase Inhibitor
22 Recruiting C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks
Condition: Hereditary Angioedema
Intervention: Drug: rhC1INH or pdC1INH
23 Completed
Has Results
C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks
Condition: Hereditary Angioedema
Interventions: Biological: C1 esterase inhibitor [human] (C1INH-nf);   Drug: Placebo (saline)
24 Completed
Has Results
C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks
Condition: Hereditary Angioedema
Interventions: Biological: C1 esterase inhibitor [human] (C1INH-nf);   Drug: Placebo (saline)
25 Completed
Has Results
Human C1 Esterase Inhibitor (C1-INH) in Subjects With Acute Abdominal or Facial Hereditary Angioedema (HAE) Attacks
Condition: Hereditary Angioedema
Interventions: Biological: C1 Esterase Inhibitor;   Biological: Placebo
26 Recruiting A Call Center During HAE Attacks (SOS HAE)
Condition: Hereditary Angioedema
Intervention: Other: phone to the call center
27 Completed Berinert P Study of Subcutaneous Versus Intravenous Administration
Condition: Hereditary Angioedema
Intervention: Drug: C1-Esterase Inhibitor
28 Not yet recruiting A Phase 2 HAE Prophylaxis Study With Recombinant Human C1 Inhibitor
Condition: Hereditary Angioedema
Intervention: Biological: Recombinant human C1 inhibitor
29 Completed Subcutaneous CINRYZE With Recombinant Human Hyaluronidase for Prevention of Angioedema Attacks
Condition: Hereditary Angioedema
Intervention: Biological: CINRYZE with rHuPH20
30 Not yet recruiting Hereditary AngioEdema, Neurobiology and Psychopathology
Conditions: Hereditary AngioEdema;   Anxiety;   Depression
Intervention: Other: Clinical and psychopathological assessment of HAE patients
31 Completed A Study to Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutaneous Route
Condition: Hereditary Angioedema Types I and II
Interventions: Biological: C1-esterase inhibitor - single intravenous dose;   Biological: C1-esterase inhibitor - subcutaneous low dose;   Biological: C1-esterase inhibitor - subcutaneous medium dose;   Biological: C1-esterase inhibitor - subcutaneous high dose
32 Completed Postmarketing Immunogenicity Study in HAE Subjects Treated With Berinert
Condition: Hereditary Angioedema Types I and II
Intervention: Biological: Berinert, lyophilisate for IV application containing 500 units (U) C1-INH to be reconstituted with 10 mL water for injection
33 Withdrawn C1-INH Compared to Placebo at the Time of Prodromal Symptoms for Hereditary Angioedema (HAE) Exacerbation
Condition: Hereditary Angioedema
Interventions: Drug: C-1-esterase;   Drug: placebo
34 Completed
Has Results
Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema
Condition: Hereditary Angioedema
Intervention: Drug: ecallantide
35 Completed
Has Results
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE
Condition: Hereditary Angioedema
Intervention: Biological: C1 inhibitor (human) [C1 INH]
36 Completed
Has Results
EASSI - Evaluation of the Safety of Self-Administration With Icatibant
Condition: Hereditary Angioedema
Intervention: Drug: Icatibant
37 Completed Safety and Efficacy of Oral BCX4161 as a Prophylactic Treatment for HAE
Condition: Hereditary Angioedema
Interventions: Drug: BCX4161;   Drug: Placebo
38 Completed
Has Results
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CINRYZE Administration
Condition: Hereditary Angioedema
Intervention: Biological: CINRYZE
39 Completed
Has Results
A Study to Evaluate the Safety and Pharmacology of Subcutaneous Administration of CINRYZE With Recombinant Human Hyaluronidase
Condition: Hereditary Angioedema
Intervention: Biological: CINRYZE with rHuPH20
40 Completed EDEMA2: Evaluation of DX-88's Effect in Mitigating Angioedema
Condition: Hereditary Angioedema (HAE)
Intervention: Drug: DX-88 (ecallantide)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-56) Show next page of results    Last Page
Indicates status has not been verified in more than two years